$Co-diagnostics (CODX.US)$ Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance Friday, 21st February at 4:00 pm The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of mole...
$Co-diagnostics (CODX.US)$ Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test Co-Diagnostics, Inc. (CODX) has completed an updated in silico analysis of its Co-Dx™ Logix Smart® Mpox (2-Gene) RUO test. The analysis shows that the test should maintain full reactivity against mpox strains circulating over the past year, including the more transmissible and severe clade Ib. This comes as the Africa CDC declared mpox a Public Health Emergency of Continental Security ...
$CODX - STOCK & OPTION PLAY FIRST SIGNED OF MORE UPTREND: $10.74 NEED IT TO BREAK OVER: $11.12 key indicator for MORE uptrend $11.27 confirmation uptrend - $11.59 mini breakout - $11.93 full breakout - $12.28 SEMI PARABOLIC - $12.84 stop loss — $10.54 & support - $10.25.$Co-diagnostics (CODX.US)$
Co-diagnostics Stock Forum
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
Friday, 21st February at 4:00 pm
The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of mole...
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test
Co-Diagnostics, Inc. (CODX) has completed an updated in silico analysis of its Co-Dx™ Logix Smart® Mpox (2-Gene) RUO test. The analysis shows that the test should maintain full reactivity against mpox strains circulating over the past year, including the more transmissible and severe clade Ib.
This comes as the Africa CDC declared mpox a Public Health Emergency of Continental Security ...
In reaction to earnings/guidance:
• $Teva Pharmaceutical Industries (TEVA.US)$ +24%(also announces agreement for opioids settlement), $Enphase Energy (ENPH.US)$ +9.5%, $Spotify Technology (SPOT.US)$ +9.2%, $RPC Inc (RES.US)$ +8.5%, $Chipotle Mexican Grill (CMG.US)$ +8.2%, $Manhattan Associates (MANH.US)$ +8.1%, $Hilton Worldwide (HLT.US)$ +6.7%, $ChampionX (CHX.US)$ +6.1%, $Mr. Cooper Group (COOP.US)$ +5.7%, $Constellium (CSTM.US)$ +5.5%, $Boston Scientific (BSX.US)$ +5.4%, ...
$Co-diagnostics (CODX.US)$- Covid play
$Exela Technologies (XELA.US)$- all time low bounce play
$Express (EXPR.US)$- value play + 52 week low
$Ford Motor (F.US)$- longer term swing / good value
By Danilo
$Methanex (MEOH.US)$ $Akamai (AKAM.US)$ $Brooklyn ImmunoTherapeutics (BTX.US)$ $Nurix Therapeutics (NRIX.US)$ $Pear Therapeutics (PEAR.US)$ $Wingstop (WING.US)$ $Co-diagnostics (CODX.US)$
FIRST SIGNED OF MORE UPTREND: $10.74
NEED IT TO BREAK OVER: $11.12
key indicator for MORE uptrend $11.27
confirmation uptrend - $11.59
mini breakout - $11.93
full breakout - $12.28
SEMI PARABOLIC - $12.84
stop loss — $10.54
& support - $10.25. $Co-diagnostics (CODX.US)$
No comment yet